Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Biotechnology Information Institute | Advances in Biopharmaceutical Technology in China

Advances in Biopharmaceutical Technology in China

A Society for Industrial Microbiology and BioPlan Associates co-publication

Every organization has a China strategy, though for many of us it is simply “ignore it.” A great opportunity exists in working with China and implementing an effective company strategy. However, winning in Asia in the new millennium will require fundamental changes in partnerships between western and Asian companies. Every company faces the question “What should our China strategy be?” But to neglect China is to forego opportunities to gain efficiency in most of the things we are trying to do. China provides opportunities that allow us to do different things and not just do things differently.

This volume provides an overview of the biopharmaceutical industry, and the state of technology. It will help the reader understand general business practice in China, analyze business opportunities and in identifying potential partners for working in China. It provides a ready reference for all aspects of the world of biopharmaceuticals in China, including general understanding, detailed technical and business descriptions, and detailed information on all types of organizations involved in biopharmaceuticals in China, whether they be companies (state owned or privately owned), universities, or government institutions.

By the Numbers:

46 Internationally Recognized Authors

23 Peer-Reviewed Chapters

1,228 Pages

15 Translated Chapters and Case Studies

19 Case Studies and China Briefs

280 Tables and Figures

380 References

Over 2,000 Index Entries

Current Listing of over 2,000 Chinese Biopharmaceuticals and Diagnostics (database)

Abstracts

Chapter 1: Introduction: A China Biopharmaceuticals Strategy

Chapter 2: An Overview of Biopharmaceutical Developments in China

Chapter 3: China's Healthcare System and the Demand for Biopharmaceutical Products

Chapter 4: China Pharmaceuticals Market Situation 2006

Chapter 5: Biopharmaceutical Strategy in China: An Analysis of Innovation, Financing Policies, Talent, and Strategic Considerations Through 2010 (11th 5-year Plan)

Chapter 6: Biopharmaceuticals in China: A Market, Import/Export, and Financial Review

Chapter 7: Pharmacy and Drug Administration in China

Chapter 8: Regulatory Requirements Applicable to Clinical Trials in China

Chapter 9: FDA Requirements Applicable to Testing and Manufacturing Pharmaceutical Products in China for the U. S. Market

Chapter 10: Protection and Enforcement of Biopharmaceutical Intellectual Property Rights in China - A Rapidly Evolving System

Chapter 11: Biopharmaceutical Industry Venture Capital Investment in Mainland China

Chapter 12: Drug Discovery and Development Partnerships: Outsourcing and Partnering with China

Chapter 13: Doing Business in China

Chapter 14: Current Status and Future Prospect of Biogeneric Companies in China

Chapter 15: Biopharmaceutical Products in China

Chapter 16: Chinese Bioindustry Parks: Evolution and Growth

Chapter 17: Organizations in China involved in Biopharmaceutical Research and Manufacturing

Chapter 18: Life Science and Health Science Education in China

Chapter 19: Biopharmaceutical Research Collaboration between Western and Chinese Life Science Organization: A Guide to Prospective Partnership

Chapter 20: Industrial Technology Developments for Chinese Biopharmaceuticals

Chapter 21: Therapeutic Proteins in China

Chapter 22: Vaccines in China: Status of the Chinese Vaccine Industry

Chapter 23: Biotechnology and Analytical Methods in the Modernization of Traditional Chinese Herbal Medicine

Chapter 24: CHINA Briefs (Miscellaneous Articles)

Author Organizations:

Arnold & Porter, LLP

Beijing BaiAo Pharmaceutical Co., Ltd.

Beijing WanTai Biological Product Co., Ltd.

Business Monitor International

CanBiotech

Chemical Industry Press (China)

Chiltern International

China National Center for Biotechnology Development

China National Development and Reform Commission, Chinese Academy of Macroeconomic Research

China National Development and Reform Commission, High-Tech Industry Department

China Pharmaceutical University, College of Life Science and Technology

Chinese Academy of Social Sciences (CASS), Institute of World Economics and Politics

Chinese Ministry of Science and Technology, National Advisory Committee for "863 High Technology Program"

Deacons Hong Kong

Fudan University, International Finance

MMD Pharmahe

Nanjing University, Department of Biochemistry

National Institutes of Health (NIH), Office of Technology Transfer

National Vaccine & Serum Institute

Perkins Coie LLP (Los Angeles)

Shandong University

Shanghai CITIC GuoJian Pharmaceutical Co., Ltd.

Shanghai Tongji University, Investment Research Institute

Shanghai Venture Capital Corporation

Shenzhen Neptunus Interlong Biotech Co., Ltd

Shenzhen ZYPH Intelligence Co., Ltd.

Sichuan University, West China School of Pharmacy

Strategic Manufacturing Worldwide, Inc.

TechNova Medical Services

Tsinghua University, School of Medicine

3DBGlobal, Inc.

Free! Purchasers of Advances in Biopharmaceutical Technology in China also receive a 1-year License to the China Biotherapeutics Database, the only comprehensive English listing of biopharmaceutical products marketed in China.
Price: $6,750.00 / €4,515.75

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions